Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 9—September 2010

Extensively Drug-Resistant Tuberculosis, Pakistan

Rumina HasanComments to Author , Kauser Jabeen, Asho Ali, Yasraba Rafiq, Rabia Laiq, Babar Malik, Mahnaz Tanveer, Ramona Groenheit, Solomon Ghebremichael, Sven Hoffner, and Zahra Hasan
Author affiliations: Author affiliations: Aga Khan University, Karachi, Pakistan (R. Hasan, K. Jabeen, A. Ali, Y. Rafiq, R. Laiq, B. Malik, M. Tanveer, Z. Hasan); Swedish Institute for Infectious Disease Control, Solna, Sweden (R. Groenheit, S. Ghebremichael, S. Hoffner)

Main Article

Table 1

Frequency of multidrug-resistance and extensively drug-resistance among Mycobacterium tuberculosis isolates, Pakistan, 2006–2009*

Year No. M. tuberculosis isolates MDR isolates, no. (%) MDR + ciprofloxacin-resistant isolates, no. (% of total MDR) Total no. XDR isolates XDR as % of total MDR
2006 1,917 728 (38) 131 (18) 11 1.5
2007 2,019 782 (39) 168 (21.5) 17 2.2
2008 2,584 991 (38) 356 (36) 32 3.2
2009 3,003 1,181 (39) 512 (43) 53† 4.5

*MDR, multidrug resistant; XDR, extensively drug resistant.
†By trend analysis (p value for trend <0.01).

Main Article

Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.